Theratechnologies Inc. (TSE:TH - Get Free Report)'s share price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$1.85 and traded as high as C$2.72. Theratechnologies shares last traded at C$2.58, with a volume of 130,950 shares trading hands.
Theratechnologies Stock Performance
The company has a quick ratio of 0.64, a current ratio of 1.10 and a debt-to-equity ratio of 562.07. The stock has a market capitalization of C$119.55 million, a PE ratio of -14.44, a PEG ratio of -8.50 and a beta of 1.73. The firm has a 50 day moving average price of C$1.87 and a 200-day moving average price of C$1.83.
Theratechnologies (TSE:TH - Get Free Report) last released its quarterly earnings data on Thursday, October 10th. The company reported C$0.09 earnings per share for the quarter. Theratechnologies had a negative net margin of 8.47% and a negative return on equity of 1,116.86%. The firm had revenue of C$30.96 million for the quarter. Research analysts expect that Theratechnologies Inc. will post 0.0298643 EPS for the current fiscal year.
Theratechnologies Company Profile
(
Get Free Report)
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
Featured Stories
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
